Quick Order Cart

Cat. No. ARG27686

KIF1C Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

KIF1C Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the KIF1C gene in the haploid HAP1 human cell line. KIF1C functions as a kinesin-3 motor protein that transports integrins and other cargo along microtubules, regulating focal adhesion dynamics and cell migration through interactions with PTPN21, Rab6, and 14-3-3 proteins. This knockout model is suitable for investigating microtubule-dependent trafficking, cell adhesion, and motility. Key applications include spastic paraplegia type 58 (SPG58) disease modeling, cancer invasion studies, and high-throughput screening for motor protein modulators, using assays such as scratch wound healing, live-cell imaging, and immunofluorescence.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KIF1C

    Gene Identifier

    NCBI Gene ID 10749

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIF1C Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for the disruption of the KIF1C gene in the HAP1 human cell line. This product provides a heterogeneous pool of cells carrying targeted gene disruption, enabling robust functional studies of KIF1C-dependent processes without the need for clonal isolation. The polyclonal format maintains genetic diversity while ensuring loss-of-function across the majority of cells.

The HAP1 cell line is an adherent, near-haploid human fibroblast-like line derived from KBM-7 cells, originally isolated from a male patient with chronic myeloid leukemia in blast crisis. Its haploid karyotype simplifies the generation of knockout models, as a single targeting event can eliminate gene function without interference from a second allele. This feature makes HAP1 an ideal platform for high-throughput genetic screening and detailed phenotypic characterization, particularly in studies of cell adhesion, migration, and cytoskeletal organization.

KIF1C encodes a microtubule-based plus-end-directed motor protein of the kinesin-3 family that is essential for the intracellular transport of integrin-containing vesicles and other cargo. It is regulated by upstream factors such as the Rab6 GTPase?CBicaudal D cargo adaptor complex, phosphorylation by protein kinase A (PKA), and binding to 14-3-3 proteins and the tyrosine phosphatase PTPN21. KIF1C directly mediates the delivery of integrins (??5??1, ??v??3) to focal adhesions, affecting the localization and turnover of paxillin and vinculin, and influencing actin polymerization and Rho GTPase activity. Interacting partners include Hook1 and the dynactin complex via PTPN21, which couples KIF1C to the microtubule network. Through these interactions, KIF1C orchestrates focal adhesion dynamics and cell migration.

In HAP1 cells, which intrinsically display strong adhesive and migratory properties, KIF1C disruption generates a powerful model to dissect the molecular mechanisms of integrin trafficking and adhesion turnover. The polyclonal knockout population captures a range of mutation events, potentially revealing hypomorphic or compensatory effects, while the haploid background ensures clear loss-of-function phenotypes. This model is particularly suited to examining the interplay between microtubule-based transport and actin cytoskeleton remodeling during cell spreading and directional movement.

These knockout cells can be employed in a variety of assays, including scratch wound healing and Transwell migration/invasion assays to quantify cell motility defects, live-cell imaging of fluorescently tagged vesicle cargo to monitor transport dynamics, and immunofluorescence staining for focal adhesion components (vinculin, paxillin) and phalloidin for actin organization. Applications span neurodegeneration research (modeling SPG58), cancer biology (assessing metastatic potential), and drug discovery (screening for modulators of kinesin motor proteins). For detailed protocols, lot-specific characterization, and technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)